Biologics Spine Sports Medicine Top Stories Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft byTim AllenDecember 11, 2025
Biologics Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration byTim AllenNovember 26, 2025
Biologics Spine Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval byTim AllenJuly 8, 2025
Regulatory Spine Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion byJosh SandbergJune 23, 2025
Biologics Spine Top Stories Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance byJosh SandbergApril 23, 2025
Biologics Regulatory Spine Ventris Medical Receives Additional FDA Clearance for Backpack® Bone Graft in the Intervertebral Disc Space byJosh SandbergApril 8, 2025
Regulatory Top Stories SurGenTec® Breaks New Ground with FDA Clearance for OsteoFlo® HydroFiber™, Receives Indication for Stand-Alone Use Equivalent to Autograft byJosh SandbergJanuary 16, 2025
Biologics Regulatory Top Stories Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System byJosh SandbergJanuary 9, 2025
Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Biologics Top Stories Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology byTim AllenJune 12, 2024
